uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health. (Övrig pediatrisk forskning/Nordvall)
Show others and affiliations
2003 (English)In: Pediatric Pulmonology, ISSN 8755-6863, Vol. 35, no 6, 433-40 p.Article in journal (Refereed) Published
Abstract [en]

Respiratory infection is the major cause of morbidity and mortality in cystic fibrosis (CF) patients. Chronic Pseudomonas aeruginosa (PA) infections ultimately occur in virtually all patients. It is impossible to eradicate PA when a patient has been chronically colonized. Immunotherapy with specific egg-yolk antibodies (IgY) may be an alternative to antibiotics for the prevention of PA infections. We wanted to determine if treatment with specific IgY can prolong the period between the first and the second PA colonization? And long-term, can the treatment diminish the number of positive PA cultures and postpone the onset of chronic colonization? CF patients gargled daily with an IgY-antibody preparation, purified from eggs of hens immunized with PA bacteria. They were compared to a group of patients who did not gargle with the preparation. Both groups had their first colonization with PA eradicated by antibiotics. The basic treatment was essentially the same in both groups. In the initial study, the period between the first and second colonization with PA was significantly prolonged for the treated vs. the control group (Kaplan-Meier P = 0.015, Breslow test). In the prolonged study, the treated group had only 2.5 sputum cultures positive for PA per 100 months of observation, and none of these patients became chronically colonized with PA. No adverse events were reported. In the control group, 13.7 cultures per 100 months of observation were positive for PA, and 5 (24%) patients became chronically colonized with PA. This feasibility study shows that antipseudomonal IgY has the potential to effectively prevent PA colonization without any severe adverse effects. A phase III study should be initiated.

Place, publisher, year, edition, pages
2003. Vol. 35, no 6, 433-40 p.
Keyword [en]
Adolescent, Adult, Child, Child; Preschool, Cystic Fibrosis/*complications/*microbiology, Feasibility Studies, Humans, Immunoglobulins/*therapeutic use, Pseudomonas Infections/*complications/*prevention & control, Research Support; Non-U.S. Gov't, Sputum/microbiology
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-74507DOI: 10.1002/ppul.10290PubMedID: 12746939OAI: oai:DiVA.org:uu-74507DiVA: diva2:102417
Available from: 2005-10-04 Created: 2005-10-04Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12746939&dopt=Citation

Search in DiVA

By author/editor
Kollberg, HansJohannesson, MarieLarsson, Anders
By organisation
Department of Women's and Children's Health
In the same journal
Pediatric Pulmonology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 114 hits
ReferencesLink to record
Permanent link

Direct link